Form SCHEDULE 13D/A Tyra Biosciences, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P. Sep 17, 2026 04:32PM
Tyra Biosciences prices $400 million stock offering at $22.03 Sep 14, 2026 06:45AM
Tyra Announces Pricing of $400 Million Underwritten Offering of Common Stock and Pre-Funded Warrants Sep 14, 2026 06:45AM
Tyra Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights May 13, 2026 08:00AM
Tyra Biosciences appoints Habib Dable to board of directors Apr 17, 2026 08:00AM


Apr 17, 2026 08:00AM Tyra Biosciences Announces Appointment of Habib Dable to its Board of Directors
Jun 6, 2025 04:51PM Form SCHEDULE 13D/A Tyra Biosciences, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Mar 31, 2025 04:54PM Form SCHEDULE 13D/A Tyra Biosciences, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 13, 2024 06:04PM Form SC 13D/A Tyra Biosciences, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Oct 22, 2024 05:12PM Form SC 13D/A Tyra Biosciences, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Mar 19, 2024 04:05PM Tyra Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights
Feb 6, 2024 04:41PM Form SC 13D/A Tyra Biosciences, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 2, 2024 08:02AM Tyra Biosciences (TYRA) Announces $200M Private Placement
Feb 2, 2024 08:00AM Tyra Biosciences, Inc. Announces $200 Million Private Placement Financing
Sep 27, 2021 04:31PM Form SC 13D Tyra Biosciences, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.